Longitudinal changes in intracardiac repolarization lability in patients with implantable cardioverter-defibrillator

Abhilash Guduru, Jason Lansdown, Daniil Chernichenko, Ronald D Berger, Larisa G. Tereshchenko

Research output: Contribution to journalArticle

Abstract

Background: While it is known that elevated baseline intracardiac repolarization lability is associated with the risk of fast ventricular tachycardia (FVT)/ventricular fibrillation (VF), the effect of its longitudinal changes on the risk of FVT/VF is unknown. Methods and Results: Near-field (NF) right ventricular (RV) intracardiac electrograms (EGMs) were recorded every 3-6 months at rest in 248 patients with structural heart disease [mean age 61.2 ± 13.3; 185(75%) male; 162(65.3%) ischemic cardiomyopathy] and implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) [201 (81%) primary prevention]. Intracardiac beat-to-beat QT variability index (QTVINF) was measured on NF RV EGM. During the first study phase (median 18 months), participants made on average 2.4 visits. Then remote follow-up was continued for an additional median period of 3 years. Average QTVINF did not change during the first year after ICD implantation (-0.342 ± 0.603 at baseline vs. -0.262 ± 0.552 at 6 months vs. -0.334 ± 0.603 at 12 months); however, it decreased thereafter (-0.510 ± 0.603 at 18 months; P = 0.042). Adjusted population-averaged GEE model showed that the odds of developing FVT/VF increased by 75% for each 1 unit increase in QTVINF. (OR 1.75 [95%CI 1.05-2.92]; P = 0.031). However, individual patient-specific QTVINF trends (increasing, decreasing, flat) varied from patient to patient. For a given patient, the odds of developing FVT/VF were not associated with increasing or decreasing QTVINF over time [OR 1.27; (95%CI 0.05-30.10); P = 0.881]. Conclusion: While on average the odds of FVT/VF increased with an increase in QTVINF, patient-specific longitudinal trends in QTVINF did not affect the odds of FVT/VF.

Original languageEnglish (US)
Article numberArticle 208
JournalFrontiers in Physiology
Volume4 AUG
DOIs
StatePublished - 2013

Fingerprint

Implantable Defibrillators
Ventricular Fibrillation
Ventricular Tachycardia
Defibrillators
Cardiac Electrophysiologic Techniques
Cardiac Resynchronization Therapy
Primary Prevention
Cardiomyopathies
Heart Diseases
Population

Keywords

  • Intracardiac electrograms
  • Longitudinal analysis
  • QT variability index
  • Repolarization lability
  • Ventricular tachyarrhythmia

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Longitudinal changes in intracardiac repolarization lability in patients with implantable cardioverter-defibrillator. / Guduru, Abhilash; Lansdown, Jason; Chernichenko, Daniil; Berger, Ronald D; Tereshchenko, Larisa G.

In: Frontiers in Physiology, Vol. 4 AUG, Article 208, 2013.

Research output: Contribution to journalArticle

Guduru, Abhilash ; Lansdown, Jason ; Chernichenko, Daniil ; Berger, Ronald D ; Tereshchenko, Larisa G. / Longitudinal changes in intracardiac repolarization lability in patients with implantable cardioverter-defibrillator. In: Frontiers in Physiology. 2013 ; Vol. 4 AUG.
@article{1f9f1efe82564c488132e4ee00e2eaf9,
title = "Longitudinal changes in intracardiac repolarization lability in patients with implantable cardioverter-defibrillator",
abstract = "Background: While it is known that elevated baseline intracardiac repolarization lability is associated with the risk of fast ventricular tachycardia (FVT)/ventricular fibrillation (VF), the effect of its longitudinal changes on the risk of FVT/VF is unknown. Methods and Results: Near-field (NF) right ventricular (RV) intracardiac electrograms (EGMs) were recorded every 3-6 months at rest in 248 patients with structural heart disease [mean age 61.2 ± 13.3; 185(75{\%}) male; 162(65.3{\%}) ischemic cardiomyopathy] and implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) [201 (81{\%}) primary prevention]. Intracardiac beat-to-beat QT variability index (QTVINF) was measured on NF RV EGM. During the first study phase (median 18 months), participants made on average 2.4 visits. Then remote follow-up was continued for an additional median period of 3 years. Average QTVINF did not change during the first year after ICD implantation (-0.342 ± 0.603 at baseline vs. -0.262 ± 0.552 at 6 months vs. -0.334 ± 0.603 at 12 months); however, it decreased thereafter (-0.510 ± 0.603 at 18 months; P = 0.042). Adjusted population-averaged GEE model showed that the odds of developing FVT/VF increased by 75{\%} for each 1 unit increase in QTVINF. (OR 1.75 [95{\%}CI 1.05-2.92]; P = 0.031). However, individual patient-specific QTVINF trends (increasing, decreasing, flat) varied from patient to patient. For a given patient, the odds of developing FVT/VF were not associated with increasing or decreasing QTVINF over time [OR 1.27; (95{\%}CI 0.05-30.10); P = 0.881]. Conclusion: While on average the odds of FVT/VF increased with an increase in QTVINF, patient-specific longitudinal trends in QTVINF did not affect the odds of FVT/VF.",
keywords = "Intracardiac electrograms, Longitudinal analysis, QT variability index, Repolarization lability, Ventricular tachyarrhythmia",
author = "Abhilash Guduru and Jason Lansdown and Daniil Chernichenko and Berger, {Ronald D} and Tereshchenko, {Larisa G.}",
year = "2013",
doi = "10.3389/fphys.2013.00208",
language = "English (US)",
volume = "4 AUG",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Longitudinal changes in intracardiac repolarization lability in patients with implantable cardioverter-defibrillator

AU - Guduru, Abhilash

AU - Lansdown, Jason

AU - Chernichenko, Daniil

AU - Berger, Ronald D

AU - Tereshchenko, Larisa G.

PY - 2013

Y1 - 2013

N2 - Background: While it is known that elevated baseline intracardiac repolarization lability is associated with the risk of fast ventricular tachycardia (FVT)/ventricular fibrillation (VF), the effect of its longitudinal changes on the risk of FVT/VF is unknown. Methods and Results: Near-field (NF) right ventricular (RV) intracardiac electrograms (EGMs) were recorded every 3-6 months at rest in 248 patients with structural heart disease [mean age 61.2 ± 13.3; 185(75%) male; 162(65.3%) ischemic cardiomyopathy] and implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) [201 (81%) primary prevention]. Intracardiac beat-to-beat QT variability index (QTVINF) was measured on NF RV EGM. During the first study phase (median 18 months), participants made on average 2.4 visits. Then remote follow-up was continued for an additional median period of 3 years. Average QTVINF did not change during the first year after ICD implantation (-0.342 ± 0.603 at baseline vs. -0.262 ± 0.552 at 6 months vs. -0.334 ± 0.603 at 12 months); however, it decreased thereafter (-0.510 ± 0.603 at 18 months; P = 0.042). Adjusted population-averaged GEE model showed that the odds of developing FVT/VF increased by 75% for each 1 unit increase in QTVINF. (OR 1.75 [95%CI 1.05-2.92]; P = 0.031). However, individual patient-specific QTVINF trends (increasing, decreasing, flat) varied from patient to patient. For a given patient, the odds of developing FVT/VF were not associated with increasing or decreasing QTVINF over time [OR 1.27; (95%CI 0.05-30.10); P = 0.881]. Conclusion: While on average the odds of FVT/VF increased with an increase in QTVINF, patient-specific longitudinal trends in QTVINF did not affect the odds of FVT/VF.

AB - Background: While it is known that elevated baseline intracardiac repolarization lability is associated with the risk of fast ventricular tachycardia (FVT)/ventricular fibrillation (VF), the effect of its longitudinal changes on the risk of FVT/VF is unknown. Methods and Results: Near-field (NF) right ventricular (RV) intracardiac electrograms (EGMs) were recorded every 3-6 months at rest in 248 patients with structural heart disease [mean age 61.2 ± 13.3; 185(75%) male; 162(65.3%) ischemic cardiomyopathy] and implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) [201 (81%) primary prevention]. Intracardiac beat-to-beat QT variability index (QTVINF) was measured on NF RV EGM. During the first study phase (median 18 months), participants made on average 2.4 visits. Then remote follow-up was continued for an additional median period of 3 years. Average QTVINF did not change during the first year after ICD implantation (-0.342 ± 0.603 at baseline vs. -0.262 ± 0.552 at 6 months vs. -0.334 ± 0.603 at 12 months); however, it decreased thereafter (-0.510 ± 0.603 at 18 months; P = 0.042). Adjusted population-averaged GEE model showed that the odds of developing FVT/VF increased by 75% for each 1 unit increase in QTVINF. (OR 1.75 [95%CI 1.05-2.92]; P = 0.031). However, individual patient-specific QTVINF trends (increasing, decreasing, flat) varied from patient to patient. For a given patient, the odds of developing FVT/VF were not associated with increasing or decreasing QTVINF over time [OR 1.27; (95%CI 0.05-30.10); P = 0.881]. Conclusion: While on average the odds of FVT/VF increased with an increase in QTVINF, patient-specific longitudinal trends in QTVINF did not affect the odds of FVT/VF.

KW - Intracardiac electrograms

KW - Longitudinal analysis

KW - QT variability index

KW - Repolarization lability

KW - Ventricular tachyarrhythmia

UR - http://www.scopus.com/inward/record.url?scp=84884567949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884567949&partnerID=8YFLogxK

U2 - 10.3389/fphys.2013.00208

DO - 10.3389/fphys.2013.00208

M3 - Article

VL - 4 AUG

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

M1 - Article 208

ER -